Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELDER: Chemotherapy Exemption in Elderly Women With ER+/HER2- Breast Cancer
NCT07826052Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Sep 2026
- Primary completion
- Sep 2031
01
Overview
Phase 2, open-label, single-arm trial in breast cancer, sponsored by Fudan University. Primary endpoint: Invasive Disease-Free Survival at 5 years. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07826052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07826052.